Astrana Health, Inc.
Astrana Health, Inc. (ASTH) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ASTH · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Astrana Health, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
ASTH insider buying and selling by quarter
ASTH insider selling · ASTH insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · ASTH ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ASTH executive sell shares · ASTH board member insider trading · ASTH insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 16, 2026 | Basho Chandan COO and CFO | Other | 8,155 | $312K | Form 4 |
| Apr 14, 2026 | Basho Chandan COO and CFO | Other | 3,870 | $113K | Form 4 |
| Apr 6, 2026 | Lam Thomas S. Director | Award | 41,667 | — | Form 4 |
| Apr 6, 2026 | Sim Kenneth T. Executive Chairman · Director | Award | 100,000 | — | Form 4 |
| Apr 6, 2026 | Sim Brandon CEO and President | Award | 201,056 | — | Form 4 |
| Apr 1, 2026 | Kumar Dinesh M. Chief Medical Officer | Award | 35,300 | — | Form 4 |
| Apr 1, 2026 | Kumar Dinesh M. Chief Medical Officer | Other | 57,980 | $1.42M⚡ | Form 4 |
| Apr 2, 2026 | Basho Chandan COO and CFO | Other | 2,092 | $52K | Form 4 |
| Mar 26, 2026 | Sobotka Glenn CAO | Other | 662 | $16K | Form 4 |
| Mar 5, 2026 | Lam Thomas S. Director | Other | 9,266 | $232K | Form 4 |
| Mar 5, 2026 | Kumar Dinesh M. Chief Medical Officer | Other | 1,697 | $43K | Form 4 |
| Mar 5, 2026 | Basho Chandan COO and CFO | Other | 1,240 | $31K | Form 4 |
| Feb 2, 2026 | Sim Brandon CEO and President | Option | 21,334 | $496K | Form 4 |
| Jan 23, 2026 | Kumar Dinesh M. Chief Medical Officer | Other | 10,759 | $292K | Form 4 |
| Jan 13, 2026 | Schmidt David Director | Option | 20,000 | $116K | Form 4 |
| Jan 13, 2026 | Schmidt David Director | Other | 4,269 | $116K | Form 4 |
| Jan 1, 2026 | Kumar Dinesh M. Chief Medical Officer | Other | 5,102 | $127K | Form 4 |
| Dec 8, 2025 | Lam Thomas S. Director | Option | 29,502 | $525K | Form 4 |
| Dec 8, 2025 | Lam Thomas S. Director | Other | 25,866 | $569K | Form 4 |
| Nov 10, 2025 | Sim Kenneth T. Executive Chairman · Director | Option | 29,502 | $525K | Form 4 |
| Nov 7, 2025 | Kitayama Mitchell W Director | Option | 12,000 | $218K | Form 4 |
| Nov 10, 2025 | Mazdyasni Matthew Director | Option | 20,000 | $364K | Form 4 |
| Nov 3, 2025 | Marsh Linda Director | Option | 20,000 | $364K | Form 4 |
| Nov 3, 2025 | Marsh Linda Director | Other | 11,033 | $364K | Form 4 |
| Oct 2, 2025 | Basho Chandan COO and CFO | Other | 1,979 | $55K | Form 4 |
Sim Kenneth T.
Executive Chairman · Director
Date
Apr 6
Shares
100,000
Price
—
Value
—
Kumar Dinesh M.
Chief Medical Officer
Date
Apr 1
Shares
57,980
Price
$24.51
Value
$1.42M ⚡
Kumar Dinesh M.
Chief Medical Officer
Date
Mar 5
Shares
1,697
Price
$25.07
Value
$43K
Kumar Dinesh M.
Chief Medical Officer
Date
Jan 23
Shares
10,759
Price
$27.16
Value
$292K
Kumar Dinesh M.
Chief Medical Officer
Date
Jan 1
Shares
5,102
Price
$24.81
Value
$127K
Sim Kenneth T.
Executive Chairman · Director
Date
Nov 10
Shares
29,502
Price
$17.78
Value
$525K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ASTH insider trading
ASTH insider trades
Astrana Health, Inc. (ASTH) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Kumar Dinesh M. (Chief Medical Officer), Basho Chandan (COO and CFO), Schmidt David (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. ASTH insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Astrana Health, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ASTH insider trading · 5 questionsThe insiders of Astrana Health, Inc. (ASTH) include executives and directors such as Kumar Dinesh M. (Chief Medical Officer), Basho Chandan (COO and CFO), Schmidt David (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026